CATALYST PHARMACEUTICALS, INC. (CPRX)

Import this data to Google Sheets with:

=jivedata("CPRX","financials")

Full statements spill as a table. For one cell: =jivedata("CPRX","Revenue") or =jivedata("CPRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CATALYST PHARMACEUTICALS, INC.

CPRX • CIK 0001369568

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$398,204	$491,734	$588,989	$596,958
Cost of Goods and Services Sold	$51,967	$68,845	$87,253	$83,817
Operating Expenses	—	$190,388	$206,460	$207,642
Selling, General and Administrative Expense	$133,710	$177,740	$193,751	$196,159
Research and Development Expense	$93,150	$12,648	$12,709	$11,483
Operating Income (Loss)	$86,812	$195,124	$257,778	$267,643
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$94,511	$216,263	$283,515	$296,458
Income Tax Expense (Benefit)	$23,101	$52,374	$69,189	$75,135
Net Income (Loss) Attributable to Parent	$71,410	$163,889	$214,326	$221,323

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$470,114	$851,411	$1,103,979	$1,147,610
Liabilities	$82,233	$123,779	$149,711	$134,913
Assets, Current	$219,329	$623,609	$894,030	$940,390
Cash and Cash Equivalents, at Carrying Value	$137,636	$517,553	$709,171	$755,859
Short-term Investments	$0	—	—	$0
Accounts Receivable, after Allowance for Credit Loss, Current	$53,514	$65,476	$126,477	$130,834
Inventory, Net	$15,644	$19,541	$37,166	$34,930
Property, Plant and Equipment, Net	$1,195	$1,354	$1,037	$994
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$723	$1,120	$1,495	$1,565
Operating Lease, Right-of-Use Asset	$2,508	$2,230	$1,935	$1,858
Liabilities, Current	$76,063	$120,678	$147,152	$132,398
Accounts Payable, Current	$14,795	$16,593	$11,202	$7,151
Accrued Liabilities, Current	$61,268	$104,085	$135,950	$125,247
Stockholders' Equity Attributable to Parent	$387,881	$727,632	$954,268	$1,012,697

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$143,600	$239,808	$208,670	$208,214
Net Cash Provided by (Used in) Investing Activities	$-293,502	$-556	$-58	$-85
Net Cash Provided by (Used in) Financing Activities	$-10,857	$140,665	$-16,994	$-32,926
Payments to Acquire Property, Plant, and Equipment	$231	$556	$58	$85
Proceeds from Issuance of Common Stock	—	$141,000	$0	$0
Payments for Repurchase of Common Stock	$6,907	$0	$25,300	$25,300

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CPRX","financials")

Full statements spill as a table. For one cell: =jivedata("CPRX","Revenue") or =jivedata("CPRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.